Ana Pena, PhD

LinkedIn

Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Ana Pena, PhD

Exagen Partners with University of Washington to Improve Lupus Diagnosing, Monitoring

Exagen is teaming up with a research lab at the University of Washington’s School of Medicine (UW Medicine)…

First Patient Dosed in Early Trial Evaluating Provention’s PRV-3279 for SLE

Provention Bio has dosed the first lupus patient enrolled in the Phase 1b/2 trial testing the safety and…

Pregnancy-associated Changes in Gut Microbiota May Contribute to Lupus Exacerbations, Mouse Study Suggests

Changes in gut bacteria, or microbiota, during pregnancy and lactation can shift the immune response towards a more pro-inflammatory state…

Detailed Picture of Protein Complex Reveals Potential Therapeutic Target for Lupus, Study Reports

Scientists have taken a high-resolution photo of a protein complex, called BRISC-SHMT2, that promotes inflammation and is thought to be…

CellCept’s Impact on Immune Pathway May Explain Its Effectiveness, Study Says

In studying how mycophenolate mofetil treatment affects immune cells and blood markers in people with…

Treatment with Tofacitinib Helps Relieve Arthritis and Rash Symptoms in Lupus Patients, Study Shows

Tofacitinib tablets, a medicine approved to treat…

GSK Recruiting Lupus Patients to Test Benlysta-Rituximab Combo in Phase 3 Trial

GlaxoSmithKline (GSK) is recruiting participants for a Phase 3 clinical trial to evaluate the effectiveness and safety of Benlysta (belimumab) in…

CAR T-cell Therapy Has Potential to Combat Lupus, Mouse Study Shows

Eliminating B-cells using a recent form of immunotherapy that employs genetically modified T-cells is…

Nephrotic Syndrome Reduces Chances of Kidney Recovery in People with Lupus Nephritis, Study Says

People with lupus nephritis who have nephrotic syndrome — loss of protein in urine, low albumin levels in…

Rituxan Fails to Treat Moderate to Severe SLE without Kidney Involvement, Trial Reanalysis Confirms

Rituxan (rituximab) is not effective at treating moderate to severe…